Published in Proc Natl Acad Sci U S A on December 21, 1999
Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science (2006) 5.89
Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci (2003) 4.83
Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition. Cell (2010) 3.71
Brain-derived neurotrophic factor. Growth Factors (2004) 3.66
A biological function for the neuronal activity-dependent component of Bdnf transcription in the development of cortical inhibition. Neuron (2008) 3.40
Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci U S A (2004) 3.37
Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry (2007) 2.93
Brain-derived neurotrophic factor and obesity in the WAGR syndrome. N Engl J Med (2008) 2.91
Neurobiology of aggression and violence. Am J Psychiatry (2008) 2.78
White to brown fat phenotypic switch induced by genetic and environmental activation of a hypothalamic-adipocyte axis. Cell Metab (2011) 2.68
Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev (2012) 2.54
Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci (2008) 2.45
New insights in the biology of BDNF synthesis and release: implications in CNS function. J Neurosci (2009) 2.40
Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. Neuron (2008) 2.36
Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms. Am J Hum Genet (2001) 2.26
Quantitative genomics of aggressive behavior in Drosophila melanogaster. PLoS Genet (2006) 2.17
Dendritically targeted Bdnf mRNA is essential for energy balance and response to leptin. Nat Med (2012) 1.90
Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc Natl Acad Sci U S A (2001) 1.85
Voluntary exercise produces antidepressant and anxiolytic behavioral effects in mice. Brain Res (2008) 1.84
Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets (2006) 1.78
Brain-derived neurotrophic factor functions as a metabotrophin to mediate the effects of exercise on cognition. Eur J Neurosci (2008) 1.74
A simple role for BDNF in learning and memory? Front Mol Neurosci (2010) 1.68
Hypothalamic dysfunction of the thrombospondin receptor α2δ-1 underlies the overeating and obesity triggered by brain-derived neurotrophic factor deficiency. J Neurosci (2014) 1.42
Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase. Proc Natl Acad Sci U S A (2001) 1.37
The influences of diet and exercise on mental health through hormesis. Ageing Res Rev (2007) 1.34
Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging. PLoS One (2010) 1.32
Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet (2003) 1.32
Brain-derived neurotrophic factor regulates hedonic feeding by acting on the mesolimbic dopamine system. J Neurosci (2010) 1.30
Molecular therapy of obesity and diabetes by a physiological autoregulatory approach. Nat Med (2009) 1.28
The influence of serotonin- and other genes on impulsive behavioral aggression and cognitive impulsivity in children with attention-deficit/hyperactivity disorder (ADHD): Findings from a family-based association test (FBAT) analysis. Behav Brain Funct (2008) 1.27
Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. Curr Alzheimer Res (2012) 1.19
Obesity susceptibility loci and dietary intake in the Look AHEAD Trial. Am J Clin Nutr (2012) 1.18
Disruption of the vasopressin 1b receptor gene impairs the attack component of aggressive behavior in mice. Genes Brain Behav (2006) 1.16
BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity. Neuropsychopharmacology (2012) 1.16
Serum brain-derived neurotrophic factor concentrations in lean and overweight children and adolescents. J Clin Endocrinol Metab (2006) 1.14
BDNF+/- mice exhibit deficits in oligodendrocyte lineage cells of the basal forebrain. Glia (2010) 1.14
Endogenous truncated TrkB.T1 receptor regulates neuronal complexity and TrkB kinase receptor function in vivo. J Neurosci (2009) 1.13
The influence of exercise on cognitive abilities. Compr Physiol (2013) 1.13
Regulation of hippocampal progenitor cell survival, proliferation and dendritic development by BDNF. Mol Neurodegener (2009) 1.10
Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons. Neuropharmacology (2008) 1.10
Central nervous system-specific knockout of steroidogenic factor 1 results in increased anxiety-like behavior. Mol Endocrinol (2008) 1.09
Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking. Psychopharmacology (Berl) (2006) 1.09
Gender-dependent modulation of brain monoamines and anxiety-like behaviors in mice with genetic serotonin transporter and BDNF deficiencies. Cell Mol Neurobiol (2006) 1.09
Mood, food, and obesity. Front Psychol (2014) 1.07
Cyclic AMP response element binding protein and brain-derived neurotrophic factor: molecules that modulate our mood? J Biosci (2006) 1.06
Brain-derived neurotrophic factor Val66Met and blood glucose: a synergistic effect on memory. Front Hum Neurosci (2008) 1.06
Ethanol-BDNF interactions: still more questions than answers. Pharmacol Ther (2008) 1.06
Genome-wide association study of anthropometric traits and evidence of interactions with age and study year in Filipino women. Obesity (Silver Spring) (2010) 1.05
Early interactions with mother and peers independently build adult social skills and shape BDNF and oxytocin receptor brain levels. Psychoneuroendocrinology (2012) 1.05
Brain-derived neurotrophic factor-dependent unmasking of "silent" synapses in the developing mouse barrel cortex. Proc Natl Acad Sci U S A (2003) 1.05
Sustained expression of brain-derived neurotrophic factor is required for maintenance of dendritic spines and normal behavior. Neuroscience (2012) 1.04
miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF. Cell Mol Life Sci (2014) 1.03
proBDNF negatively regulates neuronal remodeling, synaptic transmission, and synaptic plasticity in hippocampus. Cell Rep (2014) 1.03
Brain serotonin receptors and transporters: initiation vs. termination of escalated aggression. Psychopharmacology (Berl) (2010) 1.03
Two British women studies replicated the association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) and BMI. Eur J Hum Genet (2009) 1.02
The neurobiological bases for development of pharmacological treatments of aggressive disorders. Curr Neuropharmacol (2007) 1.02
The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy. Mol Psychiatry (2015) 1.02
Mice with altered BDNF signaling as models for mood disorders and antidepressant effects. Front Behav Neurosci (2014) 0.99
A role for p11 in the antidepressant action of brain-derived neurotrophic factor. Biol Psychiatry (2010) 0.99
Brain-derived neurotrophic factor (BDNF) in the hypothalamic ventromedial nucleus increases energy expenditure. Brain Res (2010) 0.99
Molecular and neural bases underlying roles of BDNF in the control of body weight. Front Neurosci (2013) 0.98
Glial expression of Borna disease virus phosphoprotein induces behavioral and neurological abnormalities in transgenic mice. Proc Natl Acad Sci U S A (2003) 0.97
BDNF and the central control of feeding: accidental bystander or essential player? Trends Neurosci (2013) 0.97
p75 neurotrophin receptor regulates glucose homeostasis and insulin sensitivity. Proc Natl Acad Sci U S A (2012) 0.96
The effect of increased serotonergic neurotransmission on aggression: a critical meta-analytical review of preclinical studies. Psychopharmacology (Berl) (2009) 0.94
Alcohol induced depressive-like behavior is associated with a reduction in hippocampal BDNF. Pharmacol Biochem Behav (2011) 0.94
Associations between parenting behavior and anxiety in a rodent model and a clinical sample: relationship to peripheral BDNF levels. Transl Psychiatry (2012) 0.93
Increased food intake leads to obesity and insulin resistance in the tg2576 Alzheimer's disease mouse model. Endocrinology (2010) 0.93
Weighing in the role of BDNF in the central control of eating behavior. Mol Neurobiol (2011) 0.93
Effects of exercise and diet change on cognition function and synaptic plasticity in high fat diet induced obese rats. Lipids Health Dis (2013) 0.92
Appetite enhancement and weight gain by peripheral administration of TrkB agonists in non-human primates. PLoS One (2008) 0.92
Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex. Neurochem Res (2008) 0.92
Chronic administration of brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus reverses obesity induced by high-fat diet. Am J Physiol Regul Integr Comp Physiol (2010) 0.92
Are BDNF and glucocorticoid activities calibrated? Neuroscience (2012) 0.92
Soluble beta amyloid(1-42): a critical player in producing behavioural and biochemical changes evoking depressive-related state? Br J Pharmacol (2010) 0.91
A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia. Clin Psychopharmacol Neurosci (2012) 0.90
Structural and functional modifications in glutamateric synapses following prolonged ethanol exposure. Alcohol Clin Exp Res (2006) 0.90
Effects of brain-derived neurotrophic factor on dopaminergic function and motor behavior during aging. Genes Brain Behav (2010) 0.90
Behavioral and pharmacogenetics of aggressive behavior. Curr Top Behav Neurosci (2012) 0.90
Adipose VEGF Links the White-to-Brown Fat Switch With Environmental, Genetic, and Pharmacological Stimuli in Male Mice. Endocrinology (2015) 0.89
Effects of BDNF polymorphisms on antidepressant action. Psychiatry Investig (2010) 0.89
Central expression and anorectic effect of brain-derived neurotrophic factor are regulated by circulating estradiol levels. Horm Behav (2013) 0.88
Brain-derived neurotrophic factor modulates expression of chemokine receptors in the brain. Brain Res (2008) 0.88
FTO predicts weight regain in the Look AHEAD clinical trial. Int J Obes (Lond) (2013) 0.88
Functional Role of BDNF Production from Unique Promoters in Aggression and Serotonin Signaling. Neuropsychopharmacology (2015) 0.87
Vagus nerve stimulation reduces body weight and fat mass in rats. PLoS One (2012) 0.87
BDNF-restricted knockout mice as an animal model for aggression. Genes Brain Behav (2011) 0.87
Plasma BDNF levels vary in relation to body weight in females. PLoS One (2012) 0.87
Obesogenic phenotype of offspring of dams fed a high multivitamin diet is prevented by a post-weaning high multivitamin or high folate diet. Int J Obes (Lond) (2013) 0.86
Association study of Val66Met polymorphism in brain-derived neurotrophic factor gene with clozapine-induced metabolic syndrome: preliminary results. PLoS One (2013) 0.86
BDNF deficiency and young-adult methamphetamine induce sex-specific effects on prepulse inhibition regulation. Front Cell Neurosci (2013) 0.86
Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms. Front Behav Neurosci (2014) 0.86
Brain-Derived Neurotrophic Factor: Three Ligands, Many Actions. Trans Am Clin Climatol Assoc (2015) 0.85
Neurotrophins modulate the expression of chemokine receptors in the brain. J Neurovirol (2010) 0.84
Plasma brain-derived neurotrophic factor and reverse dipping pattern of nocturnal blood pressure in patients with cardiovascular risk factors. PLoS One (2014) 0.84
Changes in attack behavior and activity in EphA5 knockout mice. Brain Res (2008) 0.84
Prenatal cigarette smoke exposure causes hyperactivity and aggressive behavior: role of altered catecholamines and BDNF. Exp Neurol (2014) 0.84
Distinctive behavioral and cellular responses to fluoxetine in the mouse model for Fragile X syndrome. Front Cell Neurosci (2014) 0.84
Neurotoxic (+)-methamphetamine treatment in rats increases brain-derived neurotrophic factor and tropomyosin receptor kinase B expression in multiple brain regions. Neuroscience (2011) 0.84
Changes in 5-HT2A-mediated behavior and 5-HT2A- and 5-HT1A receptor binding and expression in conditional brain-derived neurotrophic factor knock-out mice. Neuroscience (2010) 0.84
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev (1994) 7.11
Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci U S A (1995) 5.25
Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature (1995) 4.36
Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science (1988) 3.95
Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature (1994) 3.64
The Open-Field Test: a critical review. Psychol Bull (1976) 3.59
Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci (1995) 3.56
Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat Med (1998) 2.89
Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav (1997) 2.67
Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science (1994) 2.32
A role for BDNF in mechanosensation. Nat Neurosci (1998) 2.08
Characteristics of BDNF-induced weight loss. Exp Neurol (1995) 1.78
Absence of sensory neurons before target innervation in brain-derived neurotrophic factor-, neurotrophin 3-, and TrkC-deficient embryonic mice. J Neurosci (1997) 1.70
A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp Neurol (1995) 1.70
Blunted prolactin responses to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function. Br J Psychiatry (1992) 1.65
Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat. Exp Neurol (1997) 1.62
Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. Trends Pharmacol Sci (1997) 1.58
Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J Neurosci (1998) 1.56
The influence of fluoxetine on aggressive behavior. Neuropsychopharmacology (1996) 1.55
Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci (1995) 1.52
Serotonergic control of the organization of feeding and satiety. Behav Brain Res (1996) 1.41
Activity-dependent and hormonal regulation of neurotrophin mRNA levels in the brain--implications for neuronal plasticity. J Neurobiol (1994) 1.40
The neurobiology of suicide. Nat Med (1998) 1.33
Serotonin receptors and animal models of aggressive behavior. Pharmacopsychiatry (1995) 1.30
Brain-derived neurotrophic factor levels in the nervous system of wild-type and neurotrophin gene mutant mice. J Neurochem (1999) 1.19
BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Res (1996) 1.12
Brain 5-HT1 binding sites in depressed suicides. Psychopharmacology (Berl) (1990) 1.12
Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. J Pharmacol Exp Ther (1992) 1.10
Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice. J Neurosci (1998) 1.09
Developmental regulation of early serotonergic neuronal differentiation: the role of brain-derived neurotrophic factor and membrane depolarization. Dev Biol (1995) 1.04
Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortex. Brain Res (1988) 1.02
Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3. Brain Res (1994) 0.97
Neurochemical-neuroendocrine systems in the brain controlling macronutrient intake and metabolism. Trends Neurosci (1992) 0.96
Buspirone's efficacy in organic-induced aggression. J Clin Psychopharmacol (1994) 0.96
The serotonin hypothesis of aggression revisited. Clin Psychol Rev (1997) 0.95
Possible in vivo 5-HT reuptake blocking properties of 8-OH-DPAT assessed by measuring hippocampal extracellular 5-HT using microdialysis in rats. Br J Pharmacol (1996) 0.95
Dexfenfluramine induces Fos-like immunoreactivity in discrete brain regions in rats. Brain Res Bull (1993) 0.93
Psychopharmacology of central serotonergic systems. Pharmacopsychiatry (1995) 0.92
Interactions between 5-hydroxytryptamine receptor subtypes: is a disturbed receptor balance contributing to the symptomatology of depression in humans? Pharmacol Ther (1995) 0.88
Mean genes. Neuron (1996) 0.87
Evidence of an exocytotic-like release of [3H]5-hydroxytryptamine induced by d-fenfluramine in rat hippocampal synaptosomes. Eur J Pharmacol (1993) 0.83
A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics (2001) 15.03
Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet (1998) 5.85
Inactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infection. J Exp Med (2001) 3.64
GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science (1994) 3.63
Analysis of Hox gene expression in the chick limb bud. Development (1996) 3.47
Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev (1994) 3.40
Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence. JAMA (1997) 3.35
An essential role for C/EBPbeta in female reproduction. Genes Dev (1997) 2.96
Cerebellar long-term depression requires PKC-regulated interactions between GluR2/3 and PDZ domain-containing proteins. Neuron (2000) 2.93
Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc Natl Acad Sci U S A (2000) 2.80
Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice. Curr Biol (2001) 2.72
Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature (1998) 2.65
Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev (1992) 2.54
The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor. Cell (1991) 2.46
Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J Neurosci (1998) 2.40
Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol (1993) 2.25
Spatial shaping of cochlear innervation by temporally regulated neurotrophin expression. J Neurosci (2001) 2.16
Memory impairment in abstinent MDMA ("Ecstasy") users. Neurology (1998) 2.00
Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations. Arch Gen Psychiatry (1989) 1.86
Absence of sensory neurons before target innervation in brain-derived neurotrophic factor-, neurotrophin 3-, and TrkC-deficient embryonic mice. J Neurosci (1997) 1.70
Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res (1982) 1.70
Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc Natl Acad Sci U S A (2000) 1.70
Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res (1980) 1.70
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer. Oncogene (2011) 1.69
Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res (1980) 1.64
The status of voltage-dependent calcium channels in alpha 1E knock-out mice. J Neurosci (2000) 1.63
The rat trkC locus encodes multiple neurogenic receptors that exhibit differential response to neurotrophin-3 in PC12 cells. Neuron (1993) 1.61
Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans. Neuropsychopharmacology (1994) 1.60
Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta. Proc Natl Acad Sci U S A (1998) 1.59
Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann Neurol (1986) 1.56
Targeted mutation in the neurotrophin-3 gene results in loss of muscle sensory neurons. Proc Natl Acad Sci U S A (1994) 1.54
The bHLH-Zip transcription factor Tfeb is essential for placental vascularization. Development (1998) 1.52
Caveat emptor: editors beware. Neuropsychopharmacology (2001) 1.51
Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci (1995) 1.50
Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am J Pathol (1995) 1.49
Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res (1989) 1.48
Disrupted cortical map and absence of cortical barrels in growth-associated protein (GAP)-43 knockout mice. Proc Natl Acad Sci U S A (1999) 1.46
Acute poisoning with amphetamines (MDEA) and heroin: antagonistic effects between the two drugs. Intensive Care Med (1996) 1.38
An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity (1996) 1.38
Criteria for planning radiologic equipment replacement. Radiol Med (1999) 1.38
Demographic characteristics of the equine population of northern Britain. Vet Rec (1999) 1.38
Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase. Proc Natl Acad Sci U S A (2001) 1.37
Mutations in Cdh23 cause nonsyndromic hearing loss in waltzer mice. Genomics (2001) 1.37
NGF-stimulated retrograde transport of trkA in the mammalian nervous system. J Cell Biol (1995) 1.36
Acute phase proteins in cattle: discrimination between acute and chronic inflammation. Vet Rec (1999) 1.33
BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci (2000) 1.32
Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci (1999) 1.32
Identification of an essential nonneuronal function of neurotrophin 3 in mammalian cardiac development. Nat Genet (1996) 1.30
Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity (1996) 1.27
Lsh, a SNF2 family member, is required for normal murine development. Biochim Biophys Acta (2001) 1.25
The Mos/mitogen-activated protein kinase (MAPK) pathway regulates the size and degradation of the first polar body in maturing mouse oocytes. Proc Natl Acad Sci U S A (1996) 1.25
3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans. Addiction (1994) 1.22
Dystonia and cerebellar atrophy in Cacna1a null mice lacking P/Q calcium channel activity. FASEB J (2001) 1.21
Human nerve growth factor improves spatial memory in aged but not in young rats. J Neurosci (1994) 1.20
Bovine papillomaviral gene expression in equine sarcoid tumours. Virus Res (1999) 1.19
Isolation, microinjection, and transfer of mouse blastocysts. Methods Mol Biol (2001) 1.19
An improved method for the detection of DNA fragmentation. J Immunol Methods (1991) 1.17
Dissection of NT3 functions in vivo by gene replacement strategy. Development (2001) 1.17
Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study. Psychopharmacology (Berl) (1999) 1.12
Neurotoxicity of MDMA and related compounds: anatomic studies. Ann N Y Acad Sci (1990) 1.12
Loss of brain-derived neurotrophic factor-dependent neural crest-derived sensory neurons in neurotrophin-4 mutant mice. Proc Natl Acad Sci U S A (2000) 1.10
Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers. Brain Res (1984) 1.10
Ras-guanine nucleotide exchange factor sos2 is dispensable for mouse growth and development. Mol Cell Biol (2000) 1.07
Expression of transduced genes in mice generated by infecting blastocysts with avian leukosis virus-based retroviral vectors. Proc Natl Acad Sci U S A (1996) 1.07
Dynamic cerebral autoregulation associates with infarct size and outcome after ischemic stroke. Acta Neurol Scand (2011) 1.06
Human BRCA1 gene rescues the embryonic lethality of Brca1 mutant mice. Genesis (2001) 1.05
Germ line transmission of an inactive N-myc allele generated by homologous recombination in mouse embryonic stem cells. Mol Cell Biol (1990) 1.04
(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies. Neuropsychobiology (2000) 1.04
Trends of antimicrobial resistance in bacterial isolates from a small animal referral hospital. Vet Rec (2000) 1.02
Antimicrobial-resistance trends in bacterial isolates from companion-animal community practice in the UK. Prev Vet Med (2000) 1.02
Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortex. Brain Res (1988) 1.02
Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational users. J Clin Psychopharmacol (1991) 1.01
Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra. Brain Res (1987) 1.01
Rapid anterograde axonal transport of the cellular prion glycoprotein in the peripheral and central nervous systems. J Biol Chem (1994) 1.01
In vivo detection of short- and long-term MDMA neurotoxicity--a positron emission tomography study in the living baboon brain. Synapse (1998) 1.01
Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status. Eur Radiol (2012) 1.01
Negative stress echo: further prognostic stratification with assessment of pressure-volume relation. Int J Cardiol (2007) 1.00
Impact of injuries and disease on a cohort of two- and three-year-old thoroughbreds in training. Vet Rec (1999) 1.00
Epidemiological, clinical, haematological and biochemical characteristics of canine hypothyroidism. Vet Rec (1999) 0.99
Cerebellar GABAergic processes: evidence for critical involvement in a form of simple associative learning in the rabbit. Proc Natl Acad Sci U S A (1987) 0.98
Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity. J Neurosci (2000) 0.98
Combined structural and immunological refinement of HIV-1 HLA-B8-restricted cytotoxic T lymphocyte epitopes. Eur J Immunol (1997) 0.97
Ciliary neurotrophic factor prevents retrograde neuronal death in the adult central nervous system. Proc Natl Acad Sci U S A (1993) 0.95
Neurotrophin-3 is required for the survival-differentiation of subsets of developing enteric neurons. J Neurosci (2001) 0.95
Sentinel practice-based survey of the management and health of horses in northern Britain. Vet Rec (2001) 0.95
Two CDC25 homologues are differentially expressed during mouse development. Development (1995) 0.95
In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428. Synapse (1993) 0.95
Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function? Am J Drug Alcohol Abuse (1992) 0.95
Neurotrophin-3 induced by tri-iodothyronine in cerebellar granule cells promotes Purkinje cell differentiation. J Cell Biol (1993) 0.95
Repeatability of diagnostic ultrasonography in the assessment of the equine superficial digital flexor tendon. Equine Vet J (2001) 0.94
Deafferentation causes apoptosis in cortical sensory neurons in the adult rat. J Neurosci (1997) 0.94
Estrogens modulate experimentally induced apoptosis of granule cells in the adult hippocampus. J Comp Neurol (2001) 0.94
Mouse embryonic stem cells that express a NUP98-HOXD13 fusion protein are impaired in their ability to differentiate and can be complemented by BCR-ABL. Leukemia (2007) 0.94